Industry Outlook
The hemodialysis and peritoneal dialysis market is valued at US$ 75,662.2 Mn in 2020 and is set to grow with a compounded annual growth rate (CAGR) of 6.2% during the forecast period from 2021 to 2029. According to the latest research citing of National Kidney Foundation 10% of the global population is suffering with chronic kidney disease eventually resulting into mortality of millions of people annually due to lack of access to effective treatment. People suffering with end stage renal disorders have 2 viable options such as kidney transplantation or dialysis. Elderly population in the developed regions receive kidney dialysis as a part of access to universal healthcare.
Rapid increase in kidney transplant failure and increasing popularity of nocturnal hemodialysis drive the hemodialysis market growth
Currently hemodialysis is reigning the type segment for hemodialysis and peritoneal dialysis market. Major factors such as rampant growth in the number of kidney transplant failure and increasing popularity among patients for nocturnal hemodialysis drive the hemodialysis market growth. The limitation associated with hemodialysis is the rise in infection due to frequent use of central venous catheter causing mortality in patients suffering with end stage renal disease (ESRD). Peritoneal dialysis has gained popularity on account of higher patient compliance, low infection rate and relatively cost low in comparison to hemodialysis procedure.
Increasing number of kidney dialysis centers and trained medical professionals propel the services market growth
Services are dominating the product segment for hemodialysis and peritoneal dialysis market. The rampant growth in the number of kidney dialysis centers and trained medical professionals providing effective dialysis to in bound patients drive the services market growth. In the last decade there has been technological revolution in the devices utilized for kidney dialysis exhibit features such as portability, touchscreen, hemodiafiltration and CO2 removal. Consumables are used frequently in hemodialysis and peritoneal dialysis as majority of them are disposable in nature and reduce the rate of infection associated with both the dialysis procedures which are done 2 to 3 times weekly.
Rising prevalence of chronic kidney disease to drive the hemodialysis and peritoneal dialysis market in North America
Presently North America is leading the regional segment for hemodialysis and peritoneal dialysis market. The key attributes responsible for the dominance of North America are rising prevalence of chronic kidney disease, as per the statistics provided by Center for Disease Control and Prevention (CDC), in 2019 approximately 4.9 million U.S. citizens were diagnosed with kidney disease. Presence of major players such as DaVita, Inc., Cantel Medical Corporation, Medline Industires, Inc., etc. drive the market growth in North America. Supportive regulatory environment provided by European Medical Agency (EMA) regarding the approval of devices and consumables and rampant growth in hospitals determine the hemodialysis and peritoneal dialysis market growth In Europe. Asia Pacific will be registering impressive growth during the forecast period on account of increasing number of patients suffering with kidney failure requiring routine dialysis and emergence of local players exert competition to major players providing positive traction to the market growth in the region.
Historical & Forecast Period
This research report presents the analysis of each segment from 2019 to 2029 considering 2020 as the base year for the research. Compounded annual growth rate (CAGR) for each respective segments are calculated for the forecast period from 2021 to 2029.
Medical device manufacturers providing services, devices and consumables pertaining to hemodialysis and peritoneal dialysis are Asahi Kasei Corporation, Baxter International, Cantel Medical Corporation, DaVita, Inc., Dialysis Clinic, Inc., Fresenius Medical Care AG & Co., KGaA, Medline Industries, Inc., Merit Medical Systems, Nipro Medical Corporation and NxStage Medical, Inc.
Key questions answered in this report
- What are the latest strategic collaboration and acquisition taking place in the hemodialysis and peritoneal dialysis market?
- How is the market size and CAGR calculated for the hemodialysis and peritoneal dialysis market?
- What are the renal failure clinic manifestations and how is the dialysis performed?
- Which type is the fastest and largest growing in the hemodialysis and peritoneal dialysis market?
- Which application is the leading and fastest growing in the hemodialysis and peritoneal market?
- Which regional segment is the leading and fastest growing in the hemodialysis and peritoneal market?
This product will be delivered within 2 business days.
Table of Contents
Chapter 1. Preface
Chapter 2. Executive Summary
Chapter 3. Hemodialysis And Peritoneal Dialysis (HPD) Market: Dynamics and Future Outlook
Chapter 4. Global Hemodialysis And Peritoneal Dialysis (HPD) Market, by Type
Chapter 5. Global Hemodialysis And Peritoneal Dialysis (HPD) Market, by Product
Chapter 6. Global Hemodialysis And Peritoneal Dialysis (HPD) Market, by Geography
Chapter 7. Company Profiles
Companies Mentioned
- Asahi Kasei Corporation
- Baxter International
- Cantel Medical Corporation
- DaVita Inc.
- Dialysis Clinic Inc.
- Fresenius Medical Care AG & Co.
- KGaA
- Medline Industries Inc.
- Merit Medical Systems
- Nipro Medical Corporatio. NxStage Medical Inc.